Valneva SE Company Top Insiders
| INRLF Stock | USD 4.55 0.27 5.60% |
Valneva SE employs about 762 people. The company is managed by 10 executives with a total tenure of roughly 36 years, averaging almost 3.0 years of service per executive, having 76.2 employees per reported executive. Examination of Valneva SE's management performance can provide insight into the company performance.
| Thomas Lingelbach Chairman Chairman of the Management Board and Executive Board, Co-President CEO |
| Frederic Jacotot President Vice President General Counsel, Member of the Executive Committee |
Valneva |
Valneva SE Management Team Effectiveness
The company has return on total asset (ROA) of (0.185) % which means that it has lost $0.185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8614) %, meaning that it generated substantial loss on money invested by shareholders. Valneva SE's management efficiency ratios could be used to measure how well Valneva SE manages its routine affairs as well as how well it operates its assets and liabilities.Valneva SE shows a total of 138.22 Million outstanding shares. Valneva SE has 17.56 % of its outstanding shares held by insiders and 21.62 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Valneva SE in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Valneva SE, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Valneva SE Workforce Comparison
Valneva SE is rated third overall in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 12,770. Valneva SE holds roughly 762 in number of employees claiming about 6% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Valneva SE Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Valneva SE Price Series Summation is a cross summation of Valneva SE price series and its benchmark/peer.
Valneva SE Notable Stakeholders
A Valneva SE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Valneva SE often face trade-offs trying to please all of them. Valneva SE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Valneva SE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Lingelbach | Chairman of the Management Board and Executive Board, Co-President CEO | Profile | |
| Frederic Jacotot | Vice President General Counsel, Member of the Executive Committee | Profile | |
| Dipal Patel | Chief Board | Profile | |
| Laetitia BachelotFontaine | Investor Relations Manager | Profile | |
| JuanCarlos MD | Chief Board | Profile | |
| Gerald Strohmaier | VP Resource | Profile | |
| Peter Buhler | CFO Member | Profile | |
| Franck MBA | Chief Gen | Profile | |
| Joshua Drumm | VP Relations | Profile | |
| Perry Celentano | Interim Officer | Profile |
About Valneva SE Management Performance
The success or failure of an entity such as Valneva SE often depends on how effective the management is. Valneva SE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Valneva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Valneva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on OTC Exchange in the United States.
Valneva SE Workforce Analysis
Traditionally, organizations such as Valneva SE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Valneva SE within its industry.Valneva SE Manpower Efficiency
Return on Valneva SE Manpower
| Revenue Per Employee | 456.8K | |
| Revenue Per Executive | 34.8M | |
| Net Loss Per Employee | 96.4K | |
| Net Loss Per Executive | 7.3M | |
| Working Capital Per Employee | 64.2K | |
| Working Capital Per Executive | 4.9M |
Complementary Tools for Valneva Pink Sheet analysis
When running Valneva SE's price analysis, check to measure Valneva SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valneva SE is operating at the current time. Most of Valneva SE's value examination focuses on studying past and present price action to predict the probability of Valneva SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valneva SE's price. Additionally, you may evaluate how the addition of Valneva SE to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |